BLUESTAR GENOMICS INC has a total of 18 patent applications. Its first patent ever was published in 2019. It filed its patents most often in Canada, United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, computer technology and organic fine chemistry are SEC DEP OF THE HOME DEPARTMENT, ERAGEN BIOSCIENCES INC and RAVGEN INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 4 | |
#2 | United States | 4 | |
#3 | WIPO (World Intellectual Property Organization) | 4 | |
#4 | Australia | 2 | |
#5 | EPO (European Patent Office) | 2 | |
#6 | China | 1 | |
#7 | Singapore | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Computer technology | |
#3 | Organic fine chemistry | |
#4 | Measurement |
# | Technology | |
---|---|---|
#1 | Measuring microorganism processes | |
#2 | Healthcare informatics | |
#3 | Bioinformatics | |
#4 | Sugars | |
#5 | Steroids | |
#6 | Analysing materials | |
#7 | Electric digital data processing | |
#8 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Arensdorf Patrick A | 17 |
#2 | Levy Samuel | 12 |
#3 | Ku Chin-Jen | 10 |
#4 | Collin Francois | 10 |
#5 | Spacek Damek | 8 |
#6 | Song Chunxiao | 6 |
#7 | Ellison Christopher E | 2 |
#8 | Arensdorf Patrick | 1 |
#9 | Guler Gulfem | 1 |
Publication | Filing date | Title |
---|---|---|
US2021108274A1 | Pancreatic ductal adenocarcinoma evaluation using cell-free dna hydroxymethylation profile | |
WO2020072829A2 | Simultaneous, sequencing-based analysis of proteins, nucleosomes, and cell-free nucleic acids from a single biological sample | |
WO2020061380A1 | Cell-free dna hydroxymethylation profiles in the evaluation of pancreatic lesions | |
SG11202012585YA | Hydroxymethylation analysis of cell-free nucleic acid samples for assigning tissue of origin, and related methods of use | |
CN112105626A | Method for epigenetic analysis of DNA, in particular cell-free DNA |